A rise in tuberculosis cases in Malaysia triggered social media posts falsely claiming that the bacteria responsible for the ...
The CDC’s changes threaten to cut vaccine sales for makers including Pfizer, Moderna, Merck and more, but a legal expert ...
Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.
Novavax (NVAX) is back in focus after Q4 2025 results showed surprise profitability, with revenue of US$147.14 million and net income of US$17.53 million, supported by key vaccine partnerships and ...
Dr. Vinay Prasad, vaccine chief at the the U.S. Food and Drug Administration (FDA), said in an internal memo in November that ...
5don MSN
US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost
By Ahmed Aboulenein WASHINGTON, Feb 23 (Reuters) - U.S. Food and Drug Administration Commissioner Marty Makary on Monday defended his agency's position and record on mRNA vaccines, days after it ...
Commissioner Marty Makary defended his agency's position and record on mRNA vaccines, days after it changed course and agreed ...
Maternal respiratory syncytial virus vaccination appeared to be safe and effective for mothers with HIV and their infants, according to data presented at the Conference on Retroviruses and ...
In August last year, the Health Department cut around $500 million in mRNA research funding, with Health Secretary Robert F.
Feb 26 (Reuters) - Novavax raised its adjusted revenue forecast for 2026 on Thursday, banking on milestone payments from ...
Moderna has announced that the FDA will initiate the review of its seasonal influenza vaccine candidate, mRNA-1010.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results